Hiromu Kutsumi Selected Research

Hiromu Kutsumi Research Topics

Disease

6	Ulcer 04/2017 - 06/2002
5	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020 - 02/2004
5	Inflammation (Inflammations) 09/2016 - 01/2010
5	Pancreatitis 04/2014 - 01/2011
4	Autoimmune Pancreatitis 08/2020 - 09/2014
4	Neoplasms (Cancer) 01/2019 - 03/2009
4	Stomach Neoplasms (Stomach Cancer) 11/2013 - 07/2006
4	Peptic Ulcer (Peptic Ulcers) 05/2013 - 01/2010
3	Pathologic Constriction (Stenosis) 01/2021 - 12/2014
3	Atrophy 08/2020 - 09/2014
3	Esophagitis 03/2017 - 11/2012
3	Neoplasms, Cystic, Mucinous, and Serous 09/2016 - 11/2013
3	Colitis 11/2011 - 01/2010
3	Infections 06/2010 - 04/2008
2	Chronic Pancreatitis 03/2020 - 09/2016
2	Gastroesophageal Reflux (GERD) 03/2017 - 03/2013
2	Lymphatic Metastasis 01/2017 - 02/2014
2	Disease Progression 09/2014 - 01/2013
2	Stomach Ulcer (Gastric Ulcer) 02/2014 - 09/2010
2	Carcinoma (Carcinomatosis) 09/2011 - 02/2010
2	Hepatocellular Carcinoma (Hepatoma) 12/2010 - 04/2006
1	Acute Necrotizing Pancreatitis 12/2022
1	Hemorrhage 12/2022
1	Pancreatic Diseases (Pancreatic Disease) 03/2020
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Jaundice (Icterus) 09/2019
1	Adenoma (Adenomas) 01/2019
1	Heartburn (Pyrosis) 01/2018
1	Non-Erosive Reflux Disease 03/2017
1	Fibrosis (Cirrhosis) 01/2016
1	Esophageal Atresia 12/2014
1	Tracheoesophageal Fistula 12/2014
1	Diabetes Mellitus 09/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2014
1	Fistula 02/2014
1	Acute Pain 05/2013
1	Wounds and Injuries (Trauma) 05/2013
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2012

Drug/Important Bio-Agent (IBA)

4	AcidsIBA 01/2018 - 03/2013
4	Proton Pump InhibitorsIBA 03/2017 - 01/2010
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2013 - 01/2007
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 11/2012
3	Virulence Factors (Pathogenicity Factors)IBA 10/2010 - 07/2006
2	Biomarkers (Surrogate Marker)IBA 09/2020 - 11/2018
2	Apolipoprotein A-II (Apolipoprotein A2)IBA 09/2020 - 11/2018
2	SteroidsIBA 08/2020 - 09/2014
2	Immunoglobulin G (IgG)IBA 03/2020 - 04/2008
2	Proteins (Proteins, Gene)FDA Link 03/2020 - 11/2013
2	AntigensIBA 09/2019 - 06/2010
2	EnzymesIBA 09/2016 - 01/2011
2	Messenger RNA (mRNA)IBA 01/2016 - 02/2010
2	Pharmaceutical PreparationsIBA 05/2013 - 01/2007
2	Rabeprazole (Aciphex)FDA Link 11/2012 - 05/2011
2	Glutamic Acid (Glutamate)FDA Link 06/2012 - 11/2011
2	Amino Acids FDA Link 06/2012 - 11/2011
2	CeruletideIBA 06/2012 - 01/2011
2	Dextran SulfateIBA 11/2011 - 01/2010
2	LipopolysaccharidesIBA 09/2011 - 02/2010
2	Helicobacter pylori cagA proteinIBA 10/2010 - 07/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2010 - 01/2010
2	AnticoagulantsIBA 09/2010 - 01/2010
1	ApolipoproteinsIBA 09/2020
1	AutoantibodiesIBA 03/2020
1	AutoantigensIBA 03/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	CarbohydratesIBA 09/2019
1	thienopyridineIBA 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	Protein Isoforms (Isoforms)IBA 11/2018
1	Polyglycolic Acid (Polyglycolide)IBA 04/2017
1	Prostaglandins AIBA 04/2017
1	Cytochrome P-450 CYP2C19IBA 03/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Lipase (Acid Lipase)FDA Link 09/2016
1	Amylases FDA Link 09/2016
1	CytokinesIBA 01/2016
1	MucinsIBA 11/2013
1	Gefarnate (Ulco)IBA 11/2012
1	Dihydrotachysterol (AT 10)IBA 11/2012
1	phosphorylethanolamine (phosphoethanolamine)IBA 06/2012
1	Tricarboxylic AcidsIBA 06/2012
1	Arginine (L-Arginine)FDA Link 06/2012
1	indoleacetic acid (indole acetic acid)IBA 11/2011

Therapy/Procedure

5	Therapeutics 08/2020 - 06/2002
4	Stents 01/2018 - 10/2011
4	Drug Therapy (Chemotherapy) 04/2015 - 02/2004
1	Endoscopic Sphincterotomy 12/2022
1	Catheters 01/2021
1	Radiofrequency Ablation 01/2021
1	Sphincterotomy 01/2018
1	Splenectomy 10/2015
1	Pancreatectomy 10/2015
1	Pancreaticoduodenectomy 04/2015
1	Self Expandable Metallic Stents 04/2015
1	Gastrostomy 12/2014
1	Gas Lasers 11/2013
1	Lasers (Laser) 11/2013
1	Length of Stay 01/2013
1	Conservative Treatment 01/2013